STEVEN MELNICK, MD
Medical Practice at 31 St, Miami, FL
License number
Florida ME57151
Category
Medical Practice
Type
Cytopathology
License number
Florida ME57151
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
License number
Florida ME57151
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
2
6125 SW 31St St, Miami, FL 33155
PO Box 552011, Tampa, FL 33655
PO Box 552011, Tampa, FL 33655
Phone
(305) 666-6511
(305) 503-6320
(305) 503-6329 (Fax)
(305) 503-6320
(305) 503-6329 (Fax)
Personal information
See more information about STEVEN MELNICK at radaris.comName
Address
Phone
12777 Old Cutler Rd, Miami, FL 33156
450 Grapetree Dr APT 308, Key Biscayne, FL 33149
10865 88Th Ter, Miami, FL 33176
12777 Old Cutler Rd, Miami, FL 33156
Miami, FL
Professional information
Dr. Steven Melnick, Miami FL - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
6125 SW 31St St, Miami 33155
(305) 666-6511 (Phone)
MIAMI CHILDRENS HOSPITAL
3100 SW 62Nd Ave, Miami 33155
(305) 666-6511 (Phone), (305) 665-1576 (Fax)
MCH PSYCHIATRY
3100 SW 62Nd Ave, Miami 33155
(305) 666-6511 (Phone), (305) 663-8439 (Fax)
6125 SW 31St St, Miami 33155
(305) 666-6511 (Phone)
(305) 666-6511 (Phone)
MIAMI CHILDRENS HOSPITAL
3100 SW 62Nd Ave, Miami 33155
(305) 666-6511 (Phone), (305) 665-1576 (Fax)
MCH PSYCHIATRY
3100 SW 62Nd Ave, Miami 33155
(305) 666-6511 (Phone), (305) 663-8439 (Fax)
6125 SW 31St St, Miami 33155
(305) 666-6511 (Phone)
Certifications:
Anatomic & Clinical Pathology, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Queens University / Faculty of Medicine
Miami Chldrns Hosp
Mount Sinai Medical Center
Queens University / Faculty of Medicine
Miami Chldrns Hosp
Mount Sinai Medical Center
Steven J Melnick, Miami FL
Specialties:
Anatomic Pathology & Clinical Pathology, Clinical Pathology/Laboratory Medicine, Cytopathology
Work:
Miami Children's Hospital
3100 SW 62Nd Ave, Miami, FL 33155
3100 SW 62Nd Ave, Miami, FL 33155
Education:
Queen's University (1987)
Steven J Melnick, Miami FL
Specialties:
Pathologist
Address:
3100 Sw 62Nd Ave, Miami, FL 33155
6125 Sw 31St St, Miami, FL 33155
6125 Sw 31St St, Miami, FL 33155
Education:
Queen's School of Medicine - Doctor of Medicine
McGill University - Doctor of Philosophy
Miami Children's Hospital - Residency - Pathology
Mount Sinai Medical Center - Residency - Pathology
McGill University - Doctor of Philosophy
Miami Children's Hospital - Residency - Pathology
Mount Sinai Medical Center - Residency - Pathology
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology)
President At Stephen Melnick Appraisals, Inc.
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Real Estate
Compositions And Uses Of Amooranin Compounds
US Patent:
2009020, Aug 13, 2009
Filed:
Apr 14, 2006
Appl. No.:
11/911471
Inventors:
Cheppail Ramachandran - Miami FL, US
Steven J. Melnick - Miami FL, US
Steven J. Melnick - Miami FL, US
Assignee:
Variety Children's Hospital d/b/a Miami Children's Hospital - Miami FL
International Classification:
A61K 31/19, C07C 61/29, C07C 69/753, C07C 255/47, A61K 31/215, A61K 31/704, A61P 35/00, C12N 5/00
US Classification:
514 33, 562498, 560116, 558429, 514557, 514561, 514547, 435375
Abstract:
Amooranin (AMR) has been found to cause tumor cell death through G/M cell cycle arrest, caspase activation, and apoptosis. Furthermore, it has been demonstrated that AMR is a substrate for P-glycoprotein. Based on these activities, AMR compounds, including AMR analogs, can be used in the treatment of a number of diseases in which aberrant cellular proliferation occurs such as drug-sensitive and drug-resistant cancers, autoimmune disorders, and inflammatory diseases.
Compositions And Uses Of Amooranin Compounds
US Patent:
2006016, Jul 27, 2006
Filed:
Apr 15, 2005
Appl. No.:
11/106841
Inventors:
Cheppail Ramachandran - Miami FL, US
Steven Melnick - Miami FL, US
Steven Melnick - Miami FL, US
International Classification:
A61K 31/20, C07C 61/29
US Classification:
514559000, 562403000
Abstract:
Amooranin (AMR) has been found to cause tumor cell death through G/m cell cycle arrest, caspase activation, and apoptosis. Furthermore, it has been demonstrated that AMR is a substrate for P-glycoprotein. Based on these activities, AMR compounds can be used in the treatment of a number of diseases in which aberrant cellular proliferation occurs such as drug-sensitive and drug-resistant cancers, autoimmune disorders, and inflammatory diseases.
Materials And Methods For Immune System Stimulation
US Patent:
2006000, Jan 12, 2006
Filed:
Jul 11, 2005
Appl. No.:
11/178620
Inventors:
Steven Melnick - Miami FL, US
Cheppail Ramachandran - Miami FL, US
Cheppail Ramachandran - Miami FL, US
International Classification:
A61K 31/428
US Classification:
514367000
Abstract:
The subject invention concerns a novel polysaccharide. RR1 is an α-D-glucan polysaccharide composed of a (1→4) linked back bone and (1→6) linked branches, which has been isolated from a medicinal herb, . RR1 exhibits unique immune-stimulating properties, is non-cytotoxic, and non-proliferating to normal lymphocytes, as well as tumor cell lines. The subject invention also concerns compositions containing an RR1 compound and methods for modulating an immune response in a subject using RR1 compounds. The present invention also provides methods for the use of an RR1 compound in conjunction with an antigen to stimulate an immune response, the RR1 compound providing an adjuvant-like activity in the generation of a Th1-type immune response to the antigen.